Clinical Efficacy and Safety of Alirocumab after Acute Coronary Syndrome According to Achieved Level of Low-Density Lipoprotein Cholesterol: A Propensity Score-Matched Analysis of the ODYSSEY OUTCOMES Trial
GG Schwartz, PG Steg, ODYSSEY OUTCOMES Committees and Investigators et al. Keywords:
PCSK9 inhibition; lipoprotein(a)